BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 21619453)

  • 21. Understanding and manipulating antibiotic production in actinomycetes.
    Bibb MJ
    Biochem Soc Trans; 2013 Dec; 41(6):1355-64. PubMed ID: 24256223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chapter 5. Applying the genetics of secondary metabolism in model actinomycetes to the discovery of new antibiotics.
    van Wezel GP; McKenzie NL; Nodwell JR
    Methods Enzymol; 2009; 458():117-41. PubMed ID: 19374981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ecological Strategies Behind the Selection of Cultivable Actinomycete Strains from the Yucatan Peninsula for the Discovery of Secondary Metabolites with Antibiotic Activity.
    Parera-Valadez Y; Yam-Puc A; López-Aguiar LK; Borges-Argáez R; Figueroa-Saldivar MA; Cáceres-Farfán M; Márquez-Velázquez NA; Prieto-Davó A
    Microb Ecol; 2019 May; 77(4):839-851. PubMed ID: 30761424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marine Rare Actinomycetes: A Promising Source of Structurally Diverse and Unique Novel Natural Products.
    Subramani R; Sipkema D
    Mar Drugs; 2019 Apr; 17(5):. PubMed ID: 31035452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotics production by an actinomycete isolated from the termite gut.
    Matsui T; Tanaka J; Namihira T; Shinzato N
    J Basic Microbiol; 2012 Dec; 52(6):731-5. PubMed ID: 22359219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Secondary Metabolites from Marine Microorganisms. I. Secondary Metabolites from Marine Actinomycetes].
    Orlova TI; Bulgakova VG; Polin AN
    Antibiot Khimioter; 2015; 60(7-8):47-59. PubMed ID: 26863742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioactive rare actinomycetes from indigenous natural substrates of Andhra Pradesh.
    Ellaiah P; Raju KV; Adinarayana K; Adinarayana G; Prabhakar T; Premkumar J
    Hindustan Antibiot Bull; 2002; 44(1-4):17-24. PubMed ID: 15061589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Actinomycetes: still a source of novel antibiotics.
    Genilloud O
    Nat Prod Rep; 2017 Oct; 34(10):1203-1232. PubMed ID: 28820533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomics-Driven Natural Product Discovery in Actinomycetes.
    Niu G
    Trends Biotechnol; 2018 Mar; 36(3):238-241. PubMed ID: 29126570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and molecular engineering of sugar-containing natural product biosynthetic pathways in actinomycetes.
    Oh TJ; Mo SJ; Yoon YJ; Sohng JK
    J Microbiol Biotechnol; 2007 Dec; 17(12):1909-21. PubMed ID: 18167436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marine Actinomycetes-derived Natural Products.
    Yang C; Qian R; Xu Y; Yi J; Gu Y; Liu X; Yu H; Jiao B; Lu X; Zhang W
    Curr Top Med Chem; 2019; 19(31):2868-2918. PubMed ID: 31724505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes.
    Weber T; Charusanti P; Musiol-Kroll EM; Jiang X; Tong Y; Kim HU; Lee SY
    Trends Biotechnol; 2015 Jan; 33(1):15-26. PubMed ID: 25497361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a natural product library containing secondary metabolites produced by actinomycetes.
    Takagi M; Shin-Ya K
    J Antibiot (Tokyo); 2012 Sep; 65(9):443-7. PubMed ID: 22739538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutically active secondary metabolites of marine actinobacteria.
    Manivasagan P; Venkatesan J; Sivakumar K; Kim SK
    Microbiol Res; 2014 Apr; 169(4):262-78. PubMed ID: 23958059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marine actinobacteria: new opportunities for natural product search and discovery.
    Bull AT; Stach JE
    Trends Microbiol; 2007 Nov; 15(11):491-9. PubMed ID: 17997312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane-active metabolites produced by soil actinomycetes using chromatic phospholipid/polydiacetylene vesicles.
    Mehravar M; Sardari S; Owlia P
    Indian J Exp Biol; 2011 Dec; 49(12):946-52. PubMed ID: 22403869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on biodiversity of type I & II polyketide synthesis genes positive microorganisms].
    Xu P; Li WJ; Gao HY; Xu LH; Jiang CL
    Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):821-7. PubMed ID: 16496684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic resistance-mediated isolation of scaffold-specific natural product producers.
    Thaker MN; Waglechner N; Wright GD
    Nat Protoc; 2014; 9(6):1469-79. PubMed ID: 24874813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rare actinomycete bacteria from the shallow water sediments of the Trondheim fjord, Norway: isolation, diversity and biological activity.
    Bredholdt H; Galatenko OA; Engelhardt K; Fjaervik E; Terekhova LP; Zotchev SB
    Environ Microbiol; 2007 Nov; 9(11):2756-64. PubMed ID: 17922759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Application of molecular biology for the discovery of biosynthetic genes of polyketide and peptide antibiotics produced by actinomycetes].
    Kotowska M
    Postepy Biochem; 2005; 51(3):345-52. PubMed ID: 16381179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.